# Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines

> **NCT04379960** · — · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 192 (actual)

## Conditions studied

- The Initial Aim of This Project is to Perform in Vitro Validation of Neoepitope Candidates Selected From Available Mutanome Data

## Interventions

- **OTHER:** Peptides

## Key facts

- **NCT ID:** NCT04379960
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2021-10
- **Final completion:** 2021-10
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2022-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04379960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04379960, "Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04379960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*